Fungal Prosthetic Joint Infection in Revised Knee Arthroplasty: An Orthopaedic Surgeon’s Nightmare
Open Access
- 30 June 2022
- journal article
- case report
- Published by MDPI AG in Diagnostics
- Vol. 12 (7) , 1606
Abstract
Fungal prosthetic joint infections (PJIs), despite the fact that they are rare, represent a devastating complication. Such infections in revised knee arthroplasties pose a unique surgical and medical challenge. A rare case of Candida parapsilosis PJI in revised knee arthroplasty is reported. Furthermore, a thorough review of all published fungal PJIs cases in revised knee arthroplasties is provided. A 72-year-old female with total knee replacement surgery due to osteoarthritis 10 years ago, followed by two revision surgeries six and two years ago due to aseptic loosening, presented with signs and symptoms of septic loosening of the knee components. Resection arthroplasty and cement-spacer placement was performed and periprosthetic tissue cultures yielded Candida parapsilosis. The patient was commenced on proper antifungal treatment (AFT) for six months and then the second stage of the revision surgery was performed successfully. From 2000 to 2022, a total of 46 patients with median age 69 years [interquartile range (IQR = 10)], suffering fungal PJI occurring in revised knee arthroplasty have been reported. The median time from initial arthroplasty to symptoms’ onset was 12 months (IQR = 14). Cultures of local material (52.2%) and histology (6.5%) were the reported diagnostic method, while Candida species were the most commonly isolated fungi. Regarding surgical management, two-stage revision arthroplasty (TSRA) was performed in most cases (54.3%), with median time-interval of six months (IQR = 6) between the two stages. Regarding AFT, fluconazole was the preferred antifungal compound (78.3%), followed by voriconazole and amphotericin B (19.6% each). The median duration of AFT was five months (IQR = 4.5). Infection’s outcome was successful in 38 cases (82.6%). Fungal PJIs, especially in revised knee arthroplasties, are devastating complications. A combination of AFT and TSRA seems to be the treatment of choice. TSRA in these cases poses a special challenge, since major bone defects may be present. Therapeutic procedures remain unclear, thus additional research is needed.Keywords
This publication has 47 references indexed in Scilit:
- What Is the Success of Treatment of Hip and Knee Candidal Periprosthetic Joint Infection?Clinical Orthopaedics and Related Research, 2013
- Amphotericin B Formulations: A Comparative Review of Efficacy and ToxicityDrugs, 2013
- Management of Bone Defects in Revision Total Knee ArthroplastyJournal of Bone and Joint Surgery, 2012
- Fungal peri-prosthetic joint infection after primary total knee replacementThe Journal of Bone and Joint Surgery. British volume, 2012
- Fungal Periprosthetic Hip and Knee Joint InfectionsThe Journal of Arthroplasty, 2012
- CandidaInfection in Total Knee Arthroplasty with Successful ReimplantationThe Journal of Knee Surgery, 2010
- Micafungin plus Fluconazole in an Infected Knee with Retained Hardware due to Candida albicansAnnals of Pharmacotherapy, 2009
- Caspofungin as treatment for Candida glabrata hip infectionInternational Journal of Antimicrobial Agents, 2005
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Aspergillus fumigatus infection in a mega prosthetic total knee arthroplastyThe Journal of Arthroplasty, 2001